USA – FDA publishes final guidances on device shortage reporting, computational modeling

The US Food and Drug Administration (FDA) has published two final guidance documents for medical devices on the agency’s implementation of Section 506J of...
Could AI Become the New Quality Control Manager in Medical Device Manufacturing?

USA – Stakeholders not working together to develop AI standards, expert laments

Collective intelligence is necessary for the creation of standards for artificial intelligence. That was the message Pat Baird, senior regulatory specialist at Philips brought to...

USA – Experts call for data transparency with recalled medical devices

Over the last few years, some patients have been receiving implantable cardioverter-defibrillators (ICDs) that are subject to Class I recalls. These devices have continued...

USA – FDA highlights updated labeling for some surgical mesh products, cautions against use...

The US Food and Drug Administration (FDA) issued a letter to healthcare providers to make sure they are aware of updated warnings and precautions...

USA – FDA Clears First COVID-19 Home Antigen Test

Today, the U.S. Food and Drug Administration cleared for marketing the first over-the-counter (OTC) antigen test for COVID-19. ACON Laboratories’ Flowflex COVID-19 Antigen Home...
FDA Warns of Cybersecurity Vulnerabilities in Pacemakers, Blood Glucose Monitors

USA – FDA recognizes three new international medical device software security standards

The US Food and Drug Administration (FDA) has recognized three new standards related to software security on medical devices. The standards address taking a...

USA – FDA reiterates guidance plans on distributed and point-of-care manufacturing

The US Food and Drug Administration (FDA) this week reiterated its plan to issue draft guidance spelling out how it intends to regulate distributed...

USA – FDA extends regulatory flexibilities for PMA, HDE modifications

The US Food and Drug Administration (FDA) has published a final guidance that extends its pandemic-era policy of allowing manufacturers to make certain modifications...

USA – FDA revises final guidance on modifying remote monitoring devices

The US Food and Drug Administration (FDA) has updated final guidance on its enforcement policy for remote patient monitoring devices in an effort to...

USA – FDA revises magnetic resonance guidance to reflect updated international standard

The US Food and Drug Administration (FDA) has revised its position on magnetic resonance (MR) with updates to a pair of final guidance documents. One...

NOS PROCHAINES FORMATIONS